Author

Fabio Salvatore Macaluso 1

1 IBD Unit, 'Villa Sofia-Cervello' Hospital,Palermo,Italy

A PROPENSITY SCORE-MATCHED COMPARISON OF INFLIXIMAB AND ADALIMUMAB IN NAïVE AND NON-NAïVE PATIENTS WITH CROHN'S DISEASE: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

Ambrogio Orlando, Fabio Salvatore Macaluso, Walter Fries, Antonio Carlo Privitera, Maria Cappello, Sebastiano Siringo, Gaetano Inserra, Antonio Magnano, Roberto Di Mitri, Filippo Mocciaro, Nunzio Belluardo, Giuseppe Scarpulla, Giovanni Magri, Antonino Trovatello, Antonio Carroccio, Salvatore Genova, Carmelo Bertolami, Robe

A Propensity Score-Weighted Comparison of Vedolizumab, Adalimumab, and Golimumab in Patients with Ulcerative Colitis: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

Fabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, Maria Cappello, Barbara Scrivo, Antonio Magnano, Dario Pluchino, Salvatore Camilleri, Serena Garufi, Roberto Di Mitri, Filippo Mocciaro, Giovanni Magri, Concetta Ferracane, Michele Citrano, Francesco Graziano, Carmelo Bertolami, Sara Renna, Rosalba Orlando, Giulia

A PROPENSITY SCORE-WEIGHTED COMPARISON OF VEDOLIZUMAB, ADALIMUMAB, AND GOLIMUMAB IN PATIENTS WITH ULCERATIVE COLITIS: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

Fabio Salvatore Macaluso

A REAL LIFE COMPARISON OF THE EFFICACY OF ADALIMUMAB VERSUS GOLIMUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS. A MULTICENTER EXPERIENCE FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

Sara Renna, Filippo Mocciaro, Marco Ventimiglia, Fabio Salvatore Macaluso, Rosalba Orlando, Martina Billeci, Maria Cappello, Marco Mendolaro, ANTONINO CARLO Privitera, Concetta Ferracane, Walter Fries, Valentina Pisana, Antonio Magnano, Dario Pluchino, Gaetano Inserra, Giuseppe Scarpulla, Serena Garufi, Antonio Carroccio;;

EFFECTIVENESS AND SAFETY OF NER1006 VERSUS STANDARD BOWEL PREPARATIONS: A META-ANALYSIS OF THREE RANDOMISED PHASE-3 CLINICAL TRIALS

Marcello Fabio Maida, Fabio Salvatore Macaluso, Marco Ventimiglia, Sandro Sferrazza, Emanuele Sinagra

Effectiveness and safety of ustekinumab for the treatment of Crohn's disease in real-life studies: a meta-analysis

Fabio Salvatore Macaluso, Marcello Maida, Marco Ventimiglia, Mario Cottone, Ambrogio Orlando

EFFECTIVENESS AND SAFETY OF USTEKINUMAB FOR THE TREATMENT OF CROHN'S DISEASE IN REAL-LIFE STUDIES: A META-ANALYSIS

Fabio Salvatore Macaluso

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN BIOLOGIC-NAÏVE PATIENTS: REAL-WORLD DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD)

Fabio Salvatore Macaluso

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN BIOLOGIC-NAïVE PATIENTS: REAL-WORLD DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD)

Fabio Salvatore Macaluso, Walter Fries, Sara Renna, Anna Viola, Marco Muscianisi, Maria Cappello, laura guida, Sebastiano Siringo, Salvatore Camilleri, Serena Garufi, ANTONINO CARLO Privitera, Nunzio Belluardo, Emiliano Giangreco, Carmelo Bertolami, Roberto Vassallo, Giulia Rizzuto, Rosalba Orlando, Marco Ventimiglia, Amb

EFFECTIVENESS AND TOLERABILITY OF 1L PEG-ASC PREPARATION FOR COLONOSCOPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Marcello Fabio Maida, Sandro Sferrazza, Giuseppe Scalisi, Fabio Salvatore Macaluso, Alessandro Vitello, Gaetano Cristian Morreale, Emanuele Sinagra, Dario Schillaci, Giovanni Vettori, Francesca Rossi, Domenico Catarella, Michele Manganaro, Clara Maria Virgilio, Salvatore Camilleri

Item 1 - 10 / 26
1
2 3